The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians

NCT03819790 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

119

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Basal insulin glargine and lixisenatide
DRUG: Basal insulin Basaglar/Lantus + gliclazide MR
DRUG: Metformin

Sponsor

LMC Diabetes & Endocrinology Ltd.